SYGNIS PHARMA

Pharmaceutical preparations, excluding human biological adjusted monoclonal antibody against syncitial respiratory tract viruses, further excluding immunmodulators of syncitial respiratory tract viruses, further excluding medicines for respiratory illnesses and medicines for children, for the treatment and prevention of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Consultancy and medical and scientific research and development services in the field of pharmaceutical, pharmacological and healthcare products; technical advice for others regarding research and development of pharmaceutical preparations as well as relating to planning and constructing of plants and factories for the production of pharmaceutical preparations; scientific research, namely, in the pharmaceutical field

Medical services; medical advice regarding rehabilitation, medical services in the field of rehabilitation; healthcare for people; medical consultation and medical services in the pharmaceutical, pharmacological and medical field as well as in the field of healthcare